109 filings
Page 3 of 6
8-K
il1 4eeeoz1ewslv0fq7
13 Sep 21
Regulation FD Disclosure
6:05am
8-K
ujhf4w
10 Aug 21
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
ox2msw14lcnc8aetf
10 May 21
Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
sg6u l9wdou
29 Mar 21
Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
6:35am
8-K
zl5cznb
1 Feb 21
Regulation FD Disclosure
6:03am
8-K
8aut6td55n5aq
27 Jan 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
kfcvq 4x2iieow7h
14 Jan 21
Regulation FD Disclosure
7:00am
8-K
ryykj
28 Dec 20
Other Events
6:07am
8-K
00hpz6c
8 Dec 20
Regulation FD Disclosure
12:00am
8-K
rcn7nyw6w8imdoy6t
1 Dec 20
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
5:05pm
8-K
q6x9huxro7cjpcoagc
25 Nov 20
Entry into a Material Definitive Agreement
4:00pm
8-K
qs6qpptd
6 Nov 20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
7:55am
8-K
loi7n57uv e39
4 Nov 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
jp11apripd
19 Oct 20
Regulation FD Disclosure
6:35am
8-K
d1005wyfqgwg4wvmz
15 Sep 20
Matinas BioPharma Appoints Industry Veteran Natasha Giordano to Board of Directors
4:45pm
8-K
khy6sjrh bx
10 Aug 20
Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights
4:05pm
8-K
gz2jswd93oc3r9z
2 Jul 20
Entry into a Material Definitive Agreement
5:09pm
8-K
kdeiy807q9s
2 Jun 20
Regulation FD Disclosure
8:00am
8-K
4dazu6f
11 May 20
Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights
5:18pm
8-K
zwlh9f05o8bn fbv
9 Mar 20
Matinas BioPharma Reports Fourth Quarter and Full Year 2019
4:28pm